Norton Rose Fulbright’s healthcare and life sciences team is jointly steered by Marta Giner Asins and Karine Montagut, with the team’s varied case load including regulatory compliance, antitrust matters, and digital and data privacy issues. Asins is a reference for pharmaceutical clients, acting in both major litigation and M&A transactions. Montagut regularly advises domestic and international clients on acquisitions and disposals, while Christian Dargham leads the firm’s disputes practice on matters concerning product liability. Nadège Martin is recommended for handling cross-border data privacy issues.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: NPS ®
Key clients
- Pfizer
- Ramsay Santé
- Sanofi
- Abbott
- Medtronic
- SYNLAB
- Embecta
Work highlights
Assisting a leading French pharmaceutical company in respect of an early access authorization related to gene therapies in France and advised on related data protection issues.
Advising a leading French pharmaceutical laboratory on licensing-in transactions of e-health products, solutions in the heart failure, oncological and neurological fields.
Practice head
Marta Giner Asins; Karine Montagut
Other key lawyers
Christian Dargham; Nadège Martin